Dozens of Zantac lawsuits filed in New York state courts have been consolidated for pretrial proceedings over claims the recalled heartburn drug may cause cancer.
Despite dismissal of federal Zantac lawsuits, plaintiffs continue to file claims in state courts.
Parties have reportedly reached a settlement agreement to resolve the first Zantac lawsuit scheduled to go to trial in California state court.
A judge has ordered all federal Zantac lawsuits dismissed after questioning the science behind claims that the recalled heartburn drug is linked to an increased risk of cancer.
Plaintiffs involved in Zantac litigation have submitted new evidence from a recently published study which links Zantac use to four different types of cancer.
State courts are being flooded with thousands of lawsuits over Zantac cancers which have not been included in the consolidated federal Multidistrict Litigation.
Daubert hearings for expert witnesses slated for Zantac cancer trials will begin on September 21.
A Zantac lawsuit was settled by generic drug makers, and dropped against GSK just days before trial was set to begin in an Illinois state court.
Ahead of the first Zantac lawsuit trials, slated to begin next year, investors sold off Sanofi, GlaxoSmithKline and Pfizer stocks, anticipating massive court losses and costs.
Makers of brand-name drugs want a federal judge to exclude expert witnesses for plaintiffs, seeking a summary judgment to have Zantac cancer risk lawsuits dismissed before they can make it…
